Wolfe Research initiated coverage of Clarivate (CLVT) with a Peer Perform rating and $4-$5 fair value range. The company has a strong market share with limited competition, but faces risks from tighter university and healthcare budgets, artificial intelligence disintermediation, and a relatively high net leverage ratio, the analyst tells investors in a research note.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CLVT:
- Clarivate to provide China Petrochemical with academic research, IP solutions
- Clarivate to provide library solutions, services to University of Melbourne
- Clarivate Increases Revolving Credit by $75 Million
- Milestone Scientific appoints Hines as CEO
- Clarivate’s Mixed Performance: Strong Financials Amid Strategic Uncertainty